Peter Francis - 06 Dec 2023 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director
Signature
/s/ Peter Francis
Issuer symbol
BNTC
Transactions as of
06 Dec 2023
Net transactions value
$0
Form type
4
Filing time
07 Dec 2023, 19:56:45 UTC
Previous filing
09 Dec 2022
Next filing
11 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +35,000 $0.000000 35,000 06 Dec 2023 Common Stock 35,000 $3.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant.